Schedule 13D ownership disclosure
Madrigal Pharmaceuticals Inc
Security class unavailable · CUSIP: 558868105
Event date: 2023-06-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,545,113
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-072412
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Jun 20, 2023
- Reporting period
- Jun 15, 2023
- Description
- Schedule 13D beneficial ownership